Novel, acidic CCR2 receptor antagonists: From hit to lead

被引：15
|
作者：
Zou, D.
Zhai, H. A.
Eckman, J.
Higgins, P.
Gillard, M.
Knerr, L.
Carre, S.
Pasau, P.
Collart, P.
Grassi, J.
Libertine, L.
Nicolas, J. -M.
Schwartz, C. E.
机构：
[1] UCB Res Inc, Cambridge, MA 02139 USA
[2] UCB Pharma, B-1420 Braine lAlleud, Belgium
来源：
LETTERS IN DRUG DESIGN & DISCOVERY | 2007年 / 4卷 / 03期
关键词：
MCP-1; CCR2; chemokine receptor; antagonist; inflammation; hit to lead;
D O I：
10.2174/157018007780077381
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
High throughput screening identified a pyrrolidinone containing acidic functionality as a CCR2 antagonist of modest affinity. We describe initial SAR around this hit, including solution phase parallel synthesis for analog preparation, and we describe identification and characterization of an analog subsequently selected as a viable lead molecule for further optimization.
引用
收藏
页码：185 / 191
页数：7
相关论文
共 50 条
  • [1] Novel, acidic CCR2 receptor antagonists: Lead optimization
    Dasse, O. A.
    Evans, J. L.
    Zhai, H.-X.
    Zou, D.
    Kintigh, J. T.
    Chan, F.
    Hamilton, K.
    Hill, E.
    Eckman, J. B.
    Higgins, P. J.
    Volosov, A.
    Collart, P.
    Nicolas, J.-M.
    Kondru, R. K.
    Schwartz, C. E.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (04) : 263 - 271
  • [2] CCR2 Antagonists
    Struthers, Mary
    Pasternak, Alexander
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (13) : 1278 - 1298
  • [3] Synthesis of novel monoaryl CCR2 antagonists
    Lanter, James C.
    Markotan, Thomas P.
    Subasinghe, Nalin L.
    Lawson, Edward C.
    Sui, Zhihua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [4] Discovery of novel monoaryl CCR2 antagonists
    Lanter, James C.
    Markotan, Thomas P.
    Subasinghe, Nalin L.
    Lawson, Edward C.
    Hou, Cuifen
    Opas, Evan
    McKenney, Sandra
    Crysler, Carl
    O'Neill, John
    Johnson, Dana
    Sui, Zhihua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [5] The discovery of novel cyclohexylamide CCR2 antagonists
    Lanter, James C.
    Markotan, Thomas P.
    Zhang, Xuqing
    Subasinghe, Nalin
    Kang, Fu-An
    Hou, Cuifen
    Singer, Monica
    Opas, Evan
    McKenney, Sandra
    Crysler, Carl
    Johnson, Dana
    Molloy, Christopher J.
    Sui, Zhihua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (24) : 7496 - 7501
  • [6] Isolation and structures of novel fungal metabolites as chemokine receptor (CCR2) antagonists
    Herath, KB
    Jayasuriya, H
    Ondeyka, JG
    Polishook, JD
    Bills, GF
    Dombrowski, AW
    Cabello, A
    Vicario, PP
    Zweerink, H
    Guan, ZQ
    Singh, SB
    JOURNAL OF ANTIBIOTICS, 2005, 58 (11): : 686 - 694
  • [7] Isolation and Structures of Novel Fungal Metabolites as Chemokine Receptor (CCR2) Antagonists
    Kithsiri B Herath
    Hiranthi Jayasuriya
    John G Ondeyka
    Jon D Polishook
    Gerald F Bills
    Anne W Dombrowski
    Angeles Cabello
    Pasquale P Vicario
    Hans Zweerink
    Ziqiang Guan
    Sheo B Singh
    The Journal of Antibiotics, 2005, 58 : 686 - 694
  • [8] Novel, orally bioavailable γ-aminoamide CC chemokine receptor 2 (CCR2) antagonists
    Pasternak, Alexander
    Marino, Dominick
    Vicario, Pasquale P.
    Ayala, Julia Marie
    Cascierri, Margaret A.
    Parsons, William
    Mills, Sander G.
    MacCoss, Malcolm
    Yang, Lihu
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (16) : 4801 - 4804
  • [9] Modelling the interactions of CCR2 antagonists with their receptor.
    Blaney, FE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U906 - U906
  • [10] CCR1 and CCR2 Antagonists
    Zimmermann, Henning W.
    Sterzer, Viktor
    Sahin, Hacer
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (13) : 1539 - 1552
12345